term between 1988 and 1989, she also worked as a consultant in the Clinical Division of Bio-Rad Laboratories.

University of Florida

In 1993, Yamamoto moved to the University of Florida where she re-established the Laboratory of Comparative Immunology and Retrovirology and continued researching the vaccine. The immunization, created in 2002 and approved by the U.S. Department of Agriculture, was made from an inactivated form of the FIV

1.Previous
3.Next